Young laboratory woman with testtubes

Recent News

March 2020

aTen Therapeutics relocates to new offices at 1 Lochrin Square, Fountainbridge, Edinburgh EH3 9QA.

August 2019

Ian Abercrombie appointed Chief Executive Officer at aTen Therapeutics.

July 2019

aTen Therapeutics welcomes Kimberley Meredith on a summer work placement via the University of Edinburgh.

aTen Therapeutics

An innovative biotechnology company.

We are developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.

Tensinomab product logo

Our novel antibody with huge therapeutic potential.

© aTen Therapeutics 2020. All rights reserved